Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor Therapy

The use of immune checkpoint inhibitors (ICI) has substantially increased the overall survival of cancer patients and has revolutionized the therapeutic situation in oncology. However, not all patients and cancer types respond to ICI, or become resistant over time. Combining ICIs with therapeutic ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasti, Tahseen H., Eberhardt, Christiane S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706349/
https://www.ncbi.nlm.nih.gov/pubmed/34960142
http://dx.doi.org/10.3390/vaccines9121396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706349/
https://www.ncbi.nlm.nih.gov/pubmed/34960142
http://dx.doi.org/10.3390/vaccines9121396

Ejemplares similares